Storia in 20 fonti

FDA approves pancreatic cancer drug that nearly doubles survival time

The FDA has approved daraxonrasib (Rasonque), a revolutionary drug by Revolution Medicines, which nearly doubled survival rates in pancreatic cancer clinical trials.

Raccontata da

nbcnews.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

newsbytesapp.comStai leggendo10 h fa

FDA approves pancreatic cancer drug that nearly doubles survival time

The FDA has approved daraxonrasib (Rasonque), a revolutionary drug by Revolution Medicines, which nearly doubled survival rates in pancreatic cancer clinical trials.

originale

Timeline cronologica

mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
mercoledì 26 agosto 2026·medpagetoday.com
'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval
RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

FDA approves pancreatic cancer drug that nearly doubles survival time

Confronto fonti

FDA approves pancreatic cancer drug that nearly doubles survival time

Timeline cronologica

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug

FDA approves ‘game-changing’ pancreatic cancer drug

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

FDA approves new pancreatic cancer drug that could extend patients' lives

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival

FDA approves new pancreatic cancer drug that could extend patients' lives

FDA approves new drug Rasonque to treat advanced pancreatic cancer

Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know

FDA approves breakthrough drug for metastatic pancreatic cancer: 'A real revolution'